Gout Guideline
Guideline Status
Step 10: Final guideline published and disseminated
See a list of all clinical practice guideline project steps on the Clinical Practice Guidelines page.
On This Page
2020 Guideline for the Management of Gout
Documents related to the 2020 guideline:
Appendix 1 – Methods 2020
Appendix 2 – Panel/Teams Involved 2020
Appendix 3 – Specification of Important and Critical Outcomes Identified for the Systematic Literature Review 2020
Appendix 4 – Search Strategies 2020
Appendix 5 – Study Selection Process 2020
Appendix 6 – Network Meta-Analyses to Support Decision-Making Regarding Use of ULT 2020
Appendix 7 – Network Meta-Analyses to Support Decision-Making Regarding Use of Anti-Inflammatory Agents 2020
Appendix 8 – Evidence Report/Summary of Findings Tables 2020
Appendix 9 – Medication Costs 2020
Appendix 10 – Supplementary Figures 2020
Disclosure Summary 2020
Project Plan 2020
2012 American College of Rheumatology Guidelines for Management of Gout. Part 1: Systematic Nonpharmacologic and Pharmacologic Therapeutic Approaches to Hyperuricemia
2012 American College of Rheumatology Guidelines for Management of Gout. Part 2: Therapy and Antiinflammatory Prophylaxis of Acute Gouty Arthritis
Supplemental material for management of gout:
Figure 1 2012
Appendix A 2012
Literature review published separately:
Treatment of acute gout: A systematic review
Clarification and Rationale for Different Serum Urate Targets for Gout
July 2018 Author Statement Explaining Different Serum Urate Targets in 2012 ACR Gout Guideline and 2018 ACR Electronic Clinical Quality Measures for Gout